Mutation in katG315 is, possibly, a good prognostic marker for treatment with second-line drugs in multi-drug resistant tuberculosis: A preliminary study
[mhc_section admin_label="section"][mhc_row admin_label="row"][mhc_column type="4_4"][mhc_text admin_label="نص" background_layout="light" text_orientation="left"] Mutation in katG315 is, possibly, a good prognostic marker for treatment with second-line…